Single-cell Proteomics Market (2026 - 2033)

Single-cell Proteomics Market Summary

The global single-cell proteomics market size was valued at USD 707.1 million in 2025 and is projected to grow from USD 807.7 million in 2026 to USD 2,017.8 million by 2033, at a CAGR of 14.0% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 46.4% in 2025. Market growth is driven by increasing adoption of single-cell analysis in precision medicine, drug discovery, and disease research, along with advancements in mass spectrometry, multiplexed proteomic technologies, and high-throughput single-cell analysis platforms.

Market Dynamics

The single-cell proteomics market is witnessing strong growth, driven by rising demand for high-resolution cellular analysis, advances in mass spectrometry and other proteomic technologies, and expanding applications in drug discovery, biomarker identification, and disease research. Rising integration of single-cell proteomics with multi-omics approaches, spatial biology, and artificial intelligence is further enhancing data interpretation and expanding applications across research and clinical settings. Increasing investments in advanced proteomics platforms and the development of high-throughput analytical workflows are also expected to improve sensitivity, scalability, and reproducibility, thereby creating new opportunities for market growth.

Market Concentration & Characteristics

The single-cell proteomics industry is characterized by a high degree of innovation, driven by improvements in mass spectrometry sensitivity, throughput, automation, and computational analysis. Companies are developing platforms capable of identifying more proteins from extremely small sample sizes, improving the depth and scalability of single-cell workflows. For instance, in June 2025, Bruker launched its timsUltra AIP system, which demonstrated the ability to identify more than 5,000 proteins from a sample amount equivalent to a single HeLa cell, highlighting advances in sensitivity and throughput for single-cell proteomics.

“The new timsUltra AIP delivers a 3-fold sensitivity gain for peptide fragment ions in single-cell proteomics, which bolsters peptide sequence identifications and enables proteomic analysis at a new level of sensitivity, e.g., even for small red blood cell precursors.”

- Nikolai Slavov, Professor of Bioengineering, Director of the Single-Cell Proteomics Center at Northeastern University, and Founding Director of the Parallel Square Technology Institute

The single-cell proteomics industry is witnessing moderate M&A activity, primarily focused on expanding proteomics capabilities and strengthening integrated single-cell and multi-omics platforms. For instance, in June 2026, 10x Genomics acquired Proteintech Genomics to expand its high-plex proteomics capabilities for single-cell and spatial applications. The acquisition is expected to strengthen 10x Genomics’ portfolio by enabling integrated analysis of protein and transcriptomic data, supporting deeper characterization of cellular states and advancing multi-omic research applications.

“Biology is bigger than transcriptomics alone. Bringing scalable protein measurements into single cell and spatial biology is an important step toward richer, more predictive views of cellular state — and ultimately, virtual cell models that better reflect the complexity of living systems.”

- Ci Chu, Senior Vice President, AI-Enabled Discovery, Xaira Therapeutics

The single-cell proteomics industry is influenced by data quality, laboratory standards, and clinical research requirements, particularly as technologies transition from exploratory research toward biomarker discovery and translational applications. Requirements for reproducible sample preparation, analytical validation, data integrity, and standardized workflows can increase development and implementation requirements for proteomics platforms.

The single-cell proteomics industry is experiencing rapid product expansion, with manufacturers introducing instruments, assays, software, and automated workflows to improve sensitivity, throughput, and proteome coverage. For instance, in February 2025, Bruker introduced advances to its timsTOF Ultra platform that improved protein-group identification in single-cell proteomics by 15%-20% and peptide identification by 20%-25%, demonstrating continued enhancement of single-cell analytical performance.

The single-cell proteomics industry is witnessing moderate to high regional expansion, supported by increasing adoption of advanced proteomics technologies across research institutions, biotechnology companies, and pharmaceutical organizations. Expansion is further supported by growing investments in proteomics infrastructure, increasing availability of specialized research services, and rising collaborations between technology providers and academic or biopharmaceutical organizations across across emerging markets.

Analyst Perspective

The single-cell proteomics market is expected to grow strongly, driven by the increasing adoption of high-resolution protein analysis in cancer research, immunology, drug discovery, and precision medicine. Growing demand for detailed characterization of cellular heterogeneity is accelerating the use of advanced mass spectrometry, antibody-based, and multiplexed proteomics technologies. Technological advancements in single-cell workflows, coupled with rising investments in multi-omics research and biomarker discovery, are expected to support long-term market expansion. Market participants are focusing on improving sensitivity, throughput, automation, and workflow integration to address the evolving requirements of single-cell research.

Product & Services Insights

The consumables & reagents segment accounted for the largest revenue share of 28.7% in 2025, driven by recurring demand for antibodies, labeling reagents, sample preparation kits, enzymes, and other consumables required for single-cell proteomics workflows. Increasing adoption of high-throughput protein profiling and advanced proteomic assays further supported segment growth. For instance, in April 2025, Standard BioTools announced new proteomics offerings, including Single SOMAmer Reagents and the SomaScan Select 3.7K Assay, designed to enable sensitive protein measurement and high-plex profiling for translational and clinical research.

The services segment is expected to register the fastest CAGR over the forecast period, driven by increasing outsourcing of complex single-cell proteomics workflows to specialized service providers, reducing the need for costly instrumentation, technical expertise, and in-house bioinformatics capabilities. Growing demand for customized protein profiling, data analysis, and integrated multi-omics studies is further supporting the adoption of these services.

Technology Insights

The mass spectrometry-based proteomics segment dominated the market with a 21.2% share in 2025, driven by high sensitivity, broad proteome coverage, and improved analysis of low-input samples. According to an article published by Oxford University Press in February 2025, technological advances in mass spectrometry-based single-cell proteomics have enabled the quantification of thousands of proteins from minute samples, with improvements in sensitivity, throughput, resolution, measurement depth, accuracy, and stability.

The sequencing-based proteomics segment is expected to register a significant CAGR over the forecast period, driven by its potential to enable highly sensitive, scalable protein analysis while leveraging established sequencing workflows. Increasing research focus on single-cell protein quantification, improved molecular barcoding approaches, and the ability to analyze large numbers of proteins with high throughput are expected to support segment expansion.

Workflow Insights

The cell isolation & preparation segment dominated the market with a 20.7% share in 2025, driven by the critical role of efficient cell enrichment, isolation, and lysis in obtaining high-quality samples for downstream proteomic analysis. Growing demand for intact single-cell samples and improved microfluidic, sorting, and low-input preparation techniques are enhancing workflow reproducibility and supporting broader adoption across single-cell research applications.

The data analysis & interpretation segment is expected to register the fastest CAGR over the forecast period, driven by the increasing complexity and volume of single-cell proteomics datasets requiring advanced computational tools for protein identification, quantification, and biological interpretation. Growing integration of artificial intelligence, machine learning, and automated bioinformatics workflows is further improving data processing efficiency and enabling deeper characterization of cellular heterogeneity.

Application Insights

The drug discovery segment dominated the market with a 42.3% share in 2025, driven by the growing use of single-cell proteomics to characterize disease-associated protein changes, identify therapeutic targets, and evaluate drug responses at cellular resolution. Increasing emphasis on precision therapeutics and understanding cellular heterogeneity is further supporting adoption across target validation and preclinical research.

The clinical diagnostics segment is expected to register the fastest CAGR over the forecast period, driven by increasing demand for high-resolution biomarker identification and personalized disease profiling. According to an article published by NIH in June 2025, researchers demonstrated the use of high-sensitivity plasma proteomics to identify disease-specific protein signatures and blood-based biomarkers for neurodegenerative diseases, highlighting the potential of advanced proteomic technologies for minimally invasive clinical diagnosis.

End Use Insights

The pharmaceutical & biotechnology companies segment dominated the market with a share of 26.2% in 2025, driven by increasing application of single-cell proteomics in target identification, biomarker discovery, drug response profiling, and translational research. Growing investment in precision medicine and biologics development is further encouraging these companies to adopt high-resolution proteomic approaches to understand cellular heterogeneity and accelerate therapeutic development.

The contract research organizations segment is projected to witness the fastest CAGR, driven by increasing outsourcing of specialized single-cell proteomics studies to access advanced analytical capabilities, specialized expertise, and scalable research infrastructure. Growing demand from pharmaceutical and biotechnology companies for cost-efficient biomarker discovery, target validation, and preclinical research is further supporting the adoption of CRO-based services.

Regional Insights

North America dominated the single-cell proteomics industry, accounting for the largest revenue share of 46.4% in 2025, supported by a strong research ecosystem, advanced mass spectrometry infrastructure, and increasing development of scalable single-cell workflows. For instance, in March 2026, researchers at the University of British Columbia developed the SPIN workflow, combining machine-learning-guided cell dispensing with nanowell technology to improve protein recovery, throughput, and reproducibility in single-cell proteomics.

U.S. Single-cell Proteomics Market Trends

Single-cell Proteomics industry in the U.S. is expected to grow over the forecast period, supported by strong academic and biopharmaceutical research activity and early adoption of next-generation proteomics platforms. For instance, in February 2026, Nautilus Biotechnology unveiled its Voyager platform at US HUPO 2026, designed to analyze up to 10 billion intact proteins and proteoforms using machine-learning-powered analysis, supporting advanced proteome characterization.

"We’re excited to bring our vision of democratizing access to proteomics to fruition and share the Voyager Platform first with researchers seeking deeper insight into protein biology.”

- Parag Mallick, Ph.D., Co-Founder and Chief Scientist of Nautilus

Europe Single-cell Proteomics Market Trends

The single-cell proteomics market in Europe is expected to grow significantly, driven by established proteomics research infrastructure, increasing adoption of advanced mass spectrometry technologies, and expanding applications in biomedical and translational research. Rising investments in precision medicine, academic research, and high-sensitivity analytical platforms are further supporting the development and adoption of single-cell proteomics solutions across the region.

The UK single-cell proteomics market is supported by growing applications of single-cell proteomics in cancer and translational research. According to an article published by NIH, in June 2026, researchers at Newcastle University reported the use of single-cell proteomics to characterize cell-state heterogeneity in skin tumors, demonstrating its potential for improving tumor profiling and biological research.

The single-cell proteomics market in Germany is anticipated to grow significantly over the forecast period, supported by its strong mass spectrometry research base, expanding computational proteomics capabilities, and increasing focus on machine learning-driven data analysis. For instance, in April 2026, the Technical University of Munich introduced an advanced bioinformatics practical program focused on single-cell proteomics, covering peptide identification, machine learning, quality control, and cross-omics analysis, strengthening Germany’s capabilities in computational single-cell proteomics.

Asia Pacific Single-cell Proteomics Market Trends

Asia Pacific is expected to grow at the fastest CAGR of 15.7% during the forecast period, driven by expanding life sciences research, increasing adoption of advanced analytical technologies, and growing interest in single-cell and spatial multi-omics. The region's growing research capabilities and investments in high-throughput proteomic technologies are expected to support wider adoption across academic and pharmaceutical applications.

China single-cell proteomics market is supported by expanding proteomics research and increasing use of advanced analytical technologies in biomedical research. Growing investments in single-cell analysis, mass spectrometry, and multi-omics research are expected to strengthen the country's capabilities in high-resolution cellular characterization.

The single-cell proteomics market in Japan is expected to grow steadily, supported by its advanced analytical instrumentation industry, established biomedical research infrastructure, and increasing adoption of high-resolution cellular analysis technologies. According to an article published by the NIH, in July 2026, researchers in Japan developed an ultra-sensitive single-cell proteomics method that combines gel electrophoresis and 3D single-molecule imaging, enabling quantitative protein profiling and improved characterization of cellular state.

Latin America Single-cell Proteomics Market Trends

The Latin America single-cell proteomics market is expected to grow gradually, supported by expanding life sciences research capabilities, increasing adoption of advanced analytical technologies, and growing investments in proteomics and multi-omics research. Rising applications of high-resolution cellular analysis in disease research, biomarker discovery, and drug development are expected to further support regional market growth.

MEA Single-cell Proteomics Market Trends

The single-cell proteomics market in Japan is expected to grow gradually as research institutions expand their advanced genomics, proteomics, and precision medicine capabilities. Increasing investments in biomedical research infrastructure and adoption of advanced analytical platforms are expected to create opportunities for single-cell proteomics, particularly in translational and disease research.

Key Single-cell Proteomics Company Insights

The single-cell proteomics market comprises established life science and analytical instrumentation companies, as well as specialized providers of single-cell analysis technologies. Prominent players include Thermo Fisher Scientific Inc., Bruker, Danaher Corporation (SCIEX), Standard BioTools, BD, Agilent Technologies, Inc., Waters Corporation, 10x Genomics, Seer, Inc., Evosep Biosystems, Cellenion, Cytek Biosciences, and Quantum-Si Incorporated. These companies are pursuing product development, technological advancements, strategic collaborations, and expanded single-cell analysis capabilities to strengthen their market positions.

Key Single-cell Proteomics Companies

The following key companies have been profiled for this study on the single-cell proteomics market

• Thermo Fisher Scientific Inc.

• Bruker

• Danaher Corporation (SCIEX)

• Standard BioTools

• BD

• Agilent Technologies, Inc.

• Waters Corporation

• 10x Genomics

• Seer, Inc.

• Evosep Biosystems

• Cellenion

• Cytek Biosciences

• Quantum-Si Incorporated

Competitive Benchmarking

Recent Developments:

• In September 2026, Bruker hosted the European Symposium on Single Cell Proteomics in Vienna, Austria, showcasing advanced mass spectrometry technologies and workflows for high-sensitivity single-cell proteomics research.

• In April 2026, Thermo Fisher Scientific and Monash University expanded proteomics capabilities through the installation of the Orbitrap Astral Zoom Mass Spectrometer, advancing high-sensitivity, low-input workflows, including single-cell proteomics, and supporting deeper protein characterization for biomedical research.

"Mass spectrometry is currently in a ‘golden age’, with rapid advances in sensitivity, speed and data quality transforming what is possible in proteomics and related fields."

- Platform Director Professor Ralf Schittenhelm

Single-cell Proteomics Market Report Scope Table

Global Single-cell Proteomics Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global single-cell proteomics market report on the basis of product & services, technology, workflow, application, end use, and region.

• Product & Services Outlook (Revenue, USD Million, 2021 - 2033)

  • Instruments

  • Consumables & Reagents

  • Software

  • Services

• Technology Outlook (Revenue, USD Million, 2021 - 2033)

  • Mass Spectrometry-based Proteomics

  • Mass Cytometry-based Proteomics

  • Antibody-based Proteomics

  • Imaging-based Proteomics

  • Sequencing-based Proteomics

  • Other Technologies

• Workflow Outlook (Revenue, USD Million, 2021 - 2033)

  • Cell Isolation & Preparation

  • Protein Labeling & Barcoding

  • Protein Detection & Quantification

  • Data Acquisition

  • Data Analysis & Interpretation

• Application Outlook (Revenue, USD Million, 2021 - 2033)

  • Clinical Diagnostics

  • Drug Discovery

  • Others

• End Use Outlook (Revenue, USD Million, 2021 - 2033)

  • Pharmaceutical & Biotechnology Companies

  • Academic & Research Institutes

  • Hospitals & Clinical Research Centers

  • Contract Research Organizations

  • Other End Users

• Regional Outlook (Revenue, USD Million, 2021 - 2033)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • Thailand

    • South Korea

  • Latin America

    • Brazil

    • Argentina

  • Middle East and Africa (MEA)

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait

Research Methodology

The single-cell proteomics market figures in this report are based on a proven research process that combines executive interviews with secondary research from proprietary databases, company filings, and recognized regulatory and institutional sources. Market size is built through value-chain sizing-reconciling supply-side and demand-side estimates—and triangulated with bottom-up and top-down approaches. Every estimate passes multiple levels of expert validation before publication, with each single-cell proteomics segment quantified using the revenue-capture definitions in the table below.

Segment Definition

Delivered Customizations

This report has been delivered with the following In-depth customizations